Learn why medical device M&A success depends on design strategy, not just dealmaking, and how to scale portfolios effectively ...
Highlights from the Third Quarter Ended September 30, 2026, and Other Recent Events: "During the third quarter, Viking ...
Stockholders approved the conversion of the preferred stock issued in the June 2026 acquisition of Azora Therapeutics Azora’s ...
Since joining Intellinetics in February 2026, President and Chief Executive Officer Alison Forsythe has focused on strengthening organizational capabilities, improving operating discipline, sharpening ...
This study systematically explores the current deployment landscape of artificial intelligence in the global medical and ...
China’s chemical industry is no longer one big story. You’ve got oversupply in commodity chemicals, but real opportunity at ...
Year-over-year revenue growth for the third quarter of 35.9% driven primarily by expanding commercial customer base across healthcare, aerospace ...
A new EJNMMI Reports commentary synthesizes a landmark article collection showing how PET tracers, SPECT/CT, artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results